Jain Mudit K.

Average Profitability
<0.0001%
Insider Buys Quantity
6
Insider Buys Sum
$8.11M
Insider Sells Quantity
12
Insider Sells Sum
$1.94M

Insider Activity of Jain Mudit K.

The largest purchase of all time was on 2021-07-02 and amounted to 444444 shares of CVRx, Inc. for $8M.

The largest sale of all time was on 2019-07-15 and amounted to 9600 shares of Inspire Medical Systems, Inc. for $640,514.

Biography of Jain Mudit K.

No biography is available at this moment.

2022-02-28PurchaseCVRx, Inc.
CVRX
director
600
0.003%
$9.03$5,420-5.13%
2021-11-19PurchaseCVRx, Inc.
CVRX
director
600
0.006%
$13.69$8,213-38.88%
2021-11-18PurchaseCVRx, Inc.
CVRX
director
1,750
0.0172%
$14.63$25,607-43.58%
2021-08-12PurchaseCVRx, Inc.
CVRX
director
1,250
0.0061%
$19.72$24,656-57%
2021-07-02PurchaseCVRx, Inc.
CVRX
director
444,444
1.5612%
$18.00$8M-56.83%
2021-07-01PurchaseCVRx, Inc.
CVRX
director
2,000
0.0096%
$25.10$50,200-57.46%
2020-01-08SaleInspire Medical Systems, Inc.
INSP
director
1,000
0.0041%
$76.97$76,970+24.35%
2020-01-06SaleInspire Medical Systems, Inc.
INSP
director
1,000
0.0042%
$76.47$76,470+23.71%
2019-12-06SaleInspire Medical Systems, Inc.
INSP
director
1,000
0.0042%
$74.97$74,970+15.4%
2019-12-04SaleInspire Medical Systems, Inc.
INSP
director
600
0.0026%
$74.39$44,634+19.25%
2019-11-27SaleInspire Medical Systems, Inc.
INSP
director
600
0.0025%
$71.97$43,182+19.1%
2019-11-26SaleInspire Medical Systems, Inc.
INSP
director
6,354
0.0264%
$70.04$445,012+19.89%
2019-11-25SaleInspire Medical Systems, Inc.
INSP
director
1,000
0.0042%
$68.47$68,470+24.15%
2019-08-21SaleInspire Medical Systems, Inc.
INSP
director
1,960
0.0084%
$69.00$135,240+8.88%
2019-08-20SaleInspire Medical Systems, Inc.
INSP
director
540
0.0023%
$68.51$36,995+7.5%
2019-08-19SaleInspire Medical Systems, Inc.
INSP
director
3,500
0.0146%
$67.21$235,240+8.63%
2019-08-16SaleInspire Medical Systems, Inc.
INSP
director
980
0.0041%
$65.51$64,204+11.74%
2019-07-15SaleInspire Medical Systems, Inc.
INSP
director
9,600
0.0388%
$66.72$640,514+1.71%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.